Omlonti
NDC 84826-002, omidenepag isopropyl, solution/ drops, from Ocuvex Therapeutics, Inc..
- Product NDC
- 84826-002
- Status
- Listed
- Labeler
- Ocuvex Therapeutics, Inc.
- Dosage form
- SOLUTION/ DROPS
- Route
- OPHTHALMIC
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA215092
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/84826-002 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OMIDENEPAG ISOPROPYL.02 mg/mL
Pharmacologic classes
Prostaglandin E2 Receptor Agonist [EPC]; Prostaglandin E2 Receptor Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 84826-002-01 | 84826000201 | 1 BOTTLE, PLASTIC in 1 CARTON (84826-002-01) / 2.5 mL in 1 BOTTLE, PLASTIC |
| 84826-002-03 | 84826000203 | 3 BOTTLE, PLASTIC in 1 CARTON (84826-002-03) / 2.5 mL in 1 BOTTLE, PLASTIC |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/4258e437-7e92-4b09-baf1-01cb158cfc05
Use it
Look up 84826-002 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/84826-002 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 84826-002. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.